CBT. If it's in the midst of a turnaround as someone stated, then it's a buy (maybe).
Based on past results --- no real growth in stated bv, not so great roe--- it is not a buy (imo).
Otoh, based on past p/e it would be or could be a buy
Again otoh though, I've no idea why people in past have pushed the p/e over 20 for this company. It cannot have been for the dividend or earnings and book value growth, or roe, or anything else that I can understand.
If there's a turnaround in progress, or maybe just if the market in general improves, then I suspect that the stock will garner a higher p/e than currently, and the stock price will have improved. Just based on a retracement to its historical p/e numbers.
For me though, I'll pass on this one. Agree though, maybe best place now for CBT is on a watch list to see what develops. |
